Product Code: ETC8836444 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Mastitis remains a significant concern in the dairy industry, prompting demand for effective treatments and prevention strategies. The market includes antibiotics, vaccines, and diagnostics aimed at improving udder health and milk quality.
The bovine mastitis market in the Philippines is expanding due to the economic impact of this common dairy cattle disease. Demand for effective antibiotics, udder health products, and preventive solutions is growing, with educational initiatives helping farmers adopt better management practices.
The bovine mastitis market is challenged by low adoption of preventive measures, limited access to veterinary care, and antibiotic resistance concerns. Many small-scale farmers lack knowledge about proper herd management and mastitis prevention. Moreover, overreliance on antibiotics without proper guidance can lead to resistance issues, complicating treatment outcomes.
The Philippines Bovine Mastitis market offers significant investment opportunities, particularly as dairy farming continues to expand in the country. Mastitis is a common and costly disease that affects milk production and quality. Investments in diagnostic tools, treatments, and prevention programs for mastitis could yield high returns as farmers seek to improve the health and productivity of their herds. Investors can capitalize on this market by developing innovative solutions, including targeted antibiotics, vaccines, and herd management technologies.
Policies supporting the bovine mastitis market focus on improving animal health and dairy productivity. The Department of Agriculture (DA) runs livestock health programs that provide veterinary services, subsidized treatments, and education on mastitis prevention. The government also enforces biosecurity measures and disease surveillance to control mastitis outbreaks and ensure a stable supply of high-quality milk.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Bovine Mastitis Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Bovine Mastitis Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Bovine Mastitis Market - Industry Life Cycle |
3.4 Philippines Bovine Mastitis Market - Porter's Five Forces |
3.5 Philippines Bovine Mastitis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Bovine Mastitis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Philippines Bovine Mastitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Bovine Mastitis Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Philippines Bovine Mastitis Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Philippines Bovine Mastitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Bovine Mastitis Market Trends |
6 Philippines Bovine Mastitis Market, By Types |
6.1 Philippines Bovine Mastitis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Bovine Mastitis Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Bovine Mastitis Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.4 Philippines Bovine Mastitis Market Revenues & Volume, By Sub-clinical, 2021- 2031F |
6.2 Philippines Bovine Mastitis Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Philippines Bovine Mastitis Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.3 Philippines Bovine Mastitis Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.4 Philippines Bovine Mastitis Market Revenues & Volume, By Vaccines, 2021- 2031F |
6.2.5 Philippines Bovine Mastitis Market Revenues & Volume, By Pain Killers, 2021- 2031F |
6.2.6 Philippines Bovine Mastitis Market Revenues & Volume, By Other Products, 2021- 2031F |
6.3 Philippines Bovine Mastitis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Bovine Mastitis Market Revenues & Volume, By Intra-mammary, 2021- 2031F |
6.3.3 Philippines Bovine Mastitis Market Revenues & Volume, By Systemic, 2021- 2031F |
6.4 Philippines Bovine Mastitis Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Philippines Bovine Mastitis Market Revenues & Volume, By Lactating Period, 2021- 2031F |
6.4.3 Philippines Bovine Mastitis Market Revenues & Volume, By Dry Period, 2021- 2031F |
6.5 Philippines Bovine Mastitis Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Philippines Bovine Mastitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Philippines Bovine Mastitis Market Revenues & Volume, By Veterinary Centers, 2021- 2031F |
6.5.4 Philippines Bovine Mastitis Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 Philippines Bovine Mastitis Market Import-Export Trade Statistics |
7.1 Philippines Bovine Mastitis Market Export to Major Countries |
7.2 Philippines Bovine Mastitis Market Imports from Major Countries |
8 Philippines Bovine Mastitis Market Key Performance Indicators |
9 Philippines Bovine Mastitis Market - Opportunity Assessment |
9.1 Philippines Bovine Mastitis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Bovine Mastitis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Philippines Bovine Mastitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Bovine Mastitis Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Philippines Bovine Mastitis Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Philippines Bovine Mastitis Market - Competitive Landscape |
10.1 Philippines Bovine Mastitis Market Revenue Share, By Companies, 2024 |
10.2 Philippines Bovine Mastitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |